Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt flag Egypt · Delayed Price · Currency is EGP
91.88
-0.01 (-0.01%)
At close: May 14, 2026

EGX:PHAR Income Statement

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,4417,5915,2323,9553,409
Revenue Growth (YoY)
24.38%45.09%32.27%16.03%18.13%
Cost of Revenue
5,3004,2442,9832,3971,957
Gross Profit
4,1413,3462,2481,5581,452
Selling, General & Admin
1,2481,127788.09683.2566.08
Research & Development
70.9470.4643.2343.6834.96
Other Operating Expenses
105312.01167.2134.3560.79
Operating Expenses
1,8001,8391,038896.23674.83
Operating Income
2,3411,5071,211662776.85
Interest Expense
-1,275-928.54-388.52-195.42-136.25
Interest & Investment Income
139.6772.0526.2457.7732.11
Earnings From Equity Investments
495.5147.1174.51--
Currency Exchange Gain (Loss)
-16.17699.88139.63286.4-6.25
Other Non Operating Income (Expenses)
84.4611.041.51-20.62-24.04
EBT Excluding Unusual Items
1,7691,5091,064790.13642.41
Gain (Loss) on Sale of Assets
1.760.224.693.72.78
Pretax Income
1,7711,5091,069793.83645.19
Income Tax Expense
313.04411.83245.62150.07156.9
Earnings From Continuing Operations
1,4581,097823.31643.76488.29
Minority Interest in Earnings
-16.24-1.21-0.99-0.78-0.53
Net Income
1,4421,096822.32642.98487.75
Net Income to Common
1,4421,096822.32642.98487.75
Net Income Growth
31.57%33.25%27.89%31.83%0.25%
Shares Outstanding (Basic)
1621491499999
Shares Outstanding (Diluted)
1621491499999
Shares Change (YoY)
8.91%-50.00%-1.64%
EPS (Basic)
8.907.375.536.484.92
EPS (Diluted)
8.907.375.536.484.92
EPS Growth
20.80%33.25%-14.74%31.83%-1.36%
Free Cash Flow
-261.15-4,121-2,198-859.77-53.27
Free Cash Flow Per Share
-1.61-27.70-14.77-8.67-0.54
Dividend Per Share
-1.5001.0001.0001.500
Dividend Growth
-50.00%--33.33%-
Gross Margin
43.86%44.08%42.98%39.40%42.59%
Operating Margin
24.80%19.85%23.14%16.74%22.79%
Profit Margin
15.27%14.44%15.72%16.26%14.31%
Free Cash Flow Margin
-2.77%-54.29%-42.01%-21.74%-1.56%
EBITDA
2,4501,6071,314759.39867.73
EBITDA Margin
25.96%21.18%25.12%19.20%25.46%
D&A For EBITDA
109.46100.45103.1797.3990.88
EBIT
2,3411,5071,211662776.85
EBIT Margin
24.80%19.85%23.14%16.74%22.79%
Effective Tax Rate
17.68%27.30%22.98%18.90%24.32%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.